Founder of Ajax Therapeutics, Inc., Ross L. Levine is Chief-Translational Research at Memorial Sloan-Kettering Cancer Center and Professor at Weill Cornell Medical College and on the board of 5 other companies.

In the past he was Scientific Advisor at eFFECTOR Therapeutics, Inc.

He received a doctorate from The Johns Hopkins University School of Medicine and an undergraduate degree from Harvard College.